[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE264312T1 - (2-piperidin-1-yl-4-substituierte)-4-amino-2- chinazolin-derivate mit antihypertensiver wirkung,verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch - Google Patents

(2-piperidin-1-yl-4-substituierte)-4-amino-2- chinazolin-derivate mit antihypertensiver wirkung,verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch

Info

Publication number
ATE264312T1
ATE264312T1 AT96928398T AT96928398T ATE264312T1 AT E264312 T1 ATE264312 T1 AT E264312T1 AT 96928398 T AT96928398 T AT 96928398T AT 96928398 T AT96928398 T AT 96928398T AT E264312 T1 ATE264312 T1 AT E264312T1
Authority
AT
Austria
Prior art keywords
group
substituted
pct
methoxy
unsubstituted
Prior art date
Application number
AT96928398T
Other languages
English (en)
Inventor
Francesco Makovec
Walter Peris
Lucio Claudio Rovati
Luigi Angelo Rovati
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Application granted granted Critical
Publication of ATE264312T1 publication Critical patent/ATE264312T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96928398T 1996-04-10 1996-07-31 (2-piperidin-1-yl-4-substituierte)-4-amino-2- chinazolin-derivate mit antihypertensiver wirkung,verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch ATE264312T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96TO000275A IT1286302B1 (it) 1996-04-10 1996-04-10 Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso
PCT/EP1996/003370 WO1997037979A1 (en) 1996-04-10 1996-07-31 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use

Publications (1)

Publication Number Publication Date
ATE264312T1 true ATE264312T1 (de) 2004-04-15

Family

ID=11414541

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928398T ATE264312T1 (de) 1996-04-10 1996-07-31 (2-piperidin-1-yl-4-substituierte)-4-amino-2- chinazolin-derivate mit antihypertensiver wirkung,verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch

Country Status (11)

Country Link
US (1) US5985885A (de)
EP (1) EP0892790B1 (de)
JP (1) JP3987113B2 (de)
AT (1) ATE264312T1 (de)
AU (1) AU6788596A (de)
CA (1) CA2251308A1 (de)
DE (1) DE69632206T2 (de)
ES (1) ES2216057T3 (de)
IT (1) IT1286302B1 (de)
PT (1) PT892790E (de)
WO (1) WO1997037979A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3030561T3 (pl) 2013-08-07 2017-08-31 Cadila Healthcare Limited N-cyjanometyloamidy jako inhibitory kinaz janusowych
US9682955B2 (en) * 2014-09-09 2017-06-20 Janssen Pharmaceutica Nv Quinazoline derivatives useful as CB-1 inverse agonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
GB1383409A (en) * 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
DE3336409A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CA1307786C (en) * 1984-12-14 1992-09-22 Keiichi Yokoyama Quinazoline derivatives and antihypertensive preparations containing same as effective components
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
IT1270993B (it) * 1994-03-18 1997-05-26 Recordati Chem Pharm Derivati chinzolilamminici attivi come alfa-antagonisti

Also Published As

Publication number Publication date
DE69632206D1 (de) 2004-05-19
DE69632206T2 (de) 2005-04-28
ITTO960275A0 (de) 1996-04-10
WO1997037979A1 (en) 1997-10-16
CA2251308A1 (en) 1997-10-16
US5985885A (en) 1999-11-16
EP0892790A1 (de) 1999-01-27
JP2000508297A (ja) 2000-07-04
JP3987113B2 (ja) 2007-10-03
EP0892790B1 (de) 2004-04-14
PT892790E (pt) 2004-06-30
AU6788596A (en) 1997-10-29
ES2216057T3 (es) 2004-10-16
ITTO960275A1 (it) 1997-10-10
IT1286302B1 (it) 1998-07-08

Similar Documents

Publication Publication Date Title
Rao et al. MMP‐1 and MMP‐9 regulate epidermal growth factor‐dependent collagen loss in human carotid plaque smooth muscle cells
ATE538090T1 (de) Verfahren zur herstellung von 2-iminopyrrolidin- derivaten
WO2001019788A3 (en) BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
WO2000071508A3 (en) Inhibitors of factor Xa
NO984084L (no) 4-Amino-pyrimidin-derivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte ved fremstilling derav
TR200201413T2 (tr) Faktör Xa' nın inhibitörleri.
EP1054005A4 (de) Sulfonamidderivate, verfahren zu ihrer herstellung und ihre verwendung
BRPI0111596B8 (pt) Composto piridona, processo de produção do composto, composição farmacêutica, e uso do dito composto
DK0743307T3 (da) Sulfonamidderivat og fremgangsmåde til fremstilling deraf
TR200201168T2 (tr) CGRP-Antagonistleri-yeni siklopropanlar içeren ilaçlar ve üretim yöntemleri.
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE50106698D1 (de) Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
DK0808303T3 (da) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
ATE264312T1 (de) (2-piperidin-1-yl-4-substituierte)-4-amino-2- chinazolin-derivate mit antihypertensiver wirkung,verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch
TR200002839T2 (tr) 5-Hidroksibenzo[b]tiofen-3-karboksilik asit türevlerinin hazırlanması.
FR2738569B1 (fr) Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique
NO974945L (no) Substituerte fenylamidiner, legemidler som inneholder disse forbindelser, samt fremgangsmåte for fremstilling av disse
DK1246790T3 (da) Substituerede 1- og 2-naphthol-Mannichbaser
ATE278667T1 (de) Tetramsäure-derivate zur verwendung in medizin und lebensmitteltechnologie
KR960014105A (ko) 새로운 피리딘, 벤즈이미다졸, 이미다조피리딘 유도체 및 그의 제조방법
MX9802988A (es) Heterociclos de 5 miembros, medicamentos que contienen estos compuestos, su uso y procesos para su preparacion.

Legal Events

Date Code Title Description
EEFA Change of the company name
UEP Publication of translation of european patent specification

Ref document number: 0892790

Country of ref document: EP

REN Ceased due to non-payment of the annual fee